L. Lee-Jones
University of Wales
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by L. Lee-Jones.
Genes, Chromosomes and Cancer | 2004
L. Lee-Jones; Irene Aligianis; Peter Davies; Ana Puga; Peter A. Farndon; Anat Stemmer-Rachamimov; Vijaya Ramesh; Julian Roy Sampson
Chordomas are rare sacrococcygeal/sacral, sphenooccipital/clivus, and spinal tumors whose molecular etiology remains relatively understudied. As several anecdotal reports had described chordomas in individuals with tuberous sclerosis complex (TSC), a multisystem hamartoma syndrome, we hypothesized that the genes that cause TSC may have an etiological role in chordomas. In two cases of sacrococcygeal chordomas in individuals with TSC, one with a germ‐line TSC2 mutation and the other with a germ‐line TSC1 mutation, we confirmed somatic inactivation of the corresponding wild‐type allele by loss of heterozygosity analysis and immunohistochemistry. These data provide the first evidence of a pathogenic role by TSC genes in sacrococcygeal chordomas.
American Journal of Medical Genetics | 2001
S.L. Keeling; L. Lee-Jones; Peter Thompson
We report on an infant with Robin sequence; mild developmental delay; a left ulnar ray defect with absent ulna and associated metacarpals, carpals and phalanges; and a right ulnar nerve hypoplasia. He had a de novo interstitial deletion of 4q32-->q34. The critical region involved in the 4q terminal deletion syndrome may be 4q33. This conclusion was suggested by showing that del(4)(q31qter), del(4)(q32qter), and del(4)(q33qter) result in a similarly severe phenotype. In addition, we propose that genes for distal arm development, in particular for development of the left ulnar ray, central nervous system development, and cleft lip and palate, may be located at 4q33.
American Journal of Medical Genetics Part A | 2004
L. Lee-Jones; Tom Williams; Elizabeth Little; Julian Roy Sampson
We report a patient with trisomy X and a supernumerary marker chromosome. The marker chromosome was characterized by comparative genomic hybridization and shown to be derived from chromosome 14, resulting in trisomy for 14pter → q21. The karyotype was thus redefined as 48,XXX,+mar.rev ish enh(14pterq21). The patient presented with facial dysmorphism and a high‐pitched cry, exhibited severe developmental delay, and developed an aggressive ovarian immature teratoma. In this paper, we also review reports of 11 other patients with constitutional trisomy of the same chromosomal region. Previous studies have identified somatic gains of chromosome 14 in ovarian germ cell tumors. We propose that the constitutional gain of chromosomal 14 material may have predisposed to the development of this tumor.
Journal of Infection | 2016
Stephen A. Clark; Aiswarya Lekshmi; Jay Lucidarme; Li Hao; How Tsao; L. Lee-Jones; Kathrin U. Jansen; Lynne S. Newbold; Annaliesa S. Anderson; Ray Borrow
OBJECTIVES To compare the distribution of capsular groups and factor H-binding protein (fHBP) variants among meningococcal isolates and non-culture clinical specimens and to assess the representativeness of group B isolates amongst group B cases as a whole. METHODS A PCR sequencing assay was used to characterise fHBP from non-culture cases confirmed from January 2011 to December 2013. These were compared to genotypic data derived from whole genome analysis of isolates received during the same period. RESULTS Group W and Y strains were more common among isolates than non-culture strains. The distribution of fHBP variants among group B non-culture cases generally reflected that seen in the corresponding isolates. Nonetheless, the non-culture subset contained a greater proportion of fHBP variant 15/B44, associated with the ST-269 cluster sublineage. CONCLUSIONS Differences in capsular group and fHBP distribution among culture and non-culture cases may be indicative of variation in strain viability, diagnostic practice, disease severity and/or clinical presentation. Future analyses combining clinical case information with laboratory data may help to further explore these differences. Group B isolates provide a good representation of group B disease in E&W and, therefore, can reliably be used in fHBP strain coverage predictions of recently-licensed vaccines.
Leukemia Research | 2002
Paul Baines; Steve Austin; Janet Fisher; Eleri Owen-Jones; L. Lee-Jones; Duncan Throp; Mark McKinley; Terry Hoy; Kenneth Ian Mills; Peter Thompson; Alan Kenneth Burnett
We recorded elevated numbers of circulating myeloid and erythroid colony-forming cells in 15 adult patients with acute myeloid leukaemia (AML) who presented with high blood white cell counts. Since leukaemic blasts from three of these patients were Philadelphia chromosome-positive (Ph+), we were able to determine if blood progenitors from these particular patients arose from the leukaemic clone or from residual normal progenitors. Blasts and colonies were intensively investigated using a combination of cell surface marker analysis by flow cytometry, RT-PCR and interphase fluorescence in situ hybridization (FISH). FISH detected rearrangements within the major breakpoint BCR (M-BCR) region in blasts and in some myeloid and erythroid colonies from patients 1 and 2. The minor breakpoint (m-BCR) region was detected in blasts and in some myeloid and erythroid colonies from patient 3. RT-PCR detected long b2a2 BCR-ABL transcripts in blasts from patients 1 and 2, although misspliced short e1a2 transcripts were also seen in patient 1. Only e1a2 transcripts were found in blasts from patient 3. Flow sorting demonstrated the B-cell marker CD19 on blasts and on a proportion of myeloid and erythroid progenitors from patients 1 and 3. RT-PCR also detected IgH rearrangements, further evidence of B-cell differentiation, in blasts from these two patients. We conclude that both normal and clonal circulating progenitor numbers can be raised in both M-BCR and m-BCR Ph+ AML. The underlying cause, perhaps efflux from a congested marrow, may be common to AML patients with a high blood white cell count.
Cancer Genetics and Cytogenetics | 2004
L. Lee-Jones; Bernard Ramsahoye; Margaret Booth; Peter Thompson; Jack Whittaker; Terry Hoy
We report a case of a psu dic(6;5)(p21.3;q13) in a patient with secondary myelodysplastic syndrome (sMDS) following treatment for multiple myeloma. The abnormal chromosome was isolated by flow karyotyping and initially identified by reverse chromosome painting. The findings were then confirmed by forward painting. The value of flow karyotyping as a diagnostic technique in hematologic malignancies is discussed.
European Journal of Cancer | 2005
Wen Guo Jiang; Julian Roy Sampson; Tracey Amanda Martin; L. Lee-Jones; Gareth Watkins; Anthony Douglas-Jones; Kefah Mokbel; Robert E. Mansel
European Journal of Cancer | 2016
L. Lee-Jones; Qiuyu Wang; S. Bohan; O. Martin; Patricia E. Linton
European Journal of Cancer | 2016
Qiuyu Wang; A. Jeylani; A.K. Fallah; L. Lee-Jones; Shant Kumar; Mark Slevin
Archive | 1996
L. Lee-Jones; T. Hoy; Ken I. Mills; Alan Kenneth Burnett